Difference between revisions of "Part:BBa K4414024"

Revision as of 05:39, 9 October 2022 (view source) Jinshiyin (Talk | contribs) ← Older edit		Revision as of 05:40, 9 October 2022 (view source) Jinshiyin (Talk | contribs) Newer edit →
Line 53:		Line 53:
	<img src="https://static.igem.wiki/teams/4414/wiki/24-3.png		<img src="https://static.igem.wiki/teams/4414/wiki/24-3.png
	" class="figure-img img-fluid rounded"  height="350px">		" class="figure-img img-fluid rounded"  height="350px">
−
	</figure>		</figure>
Line 60:		Line 59:
	</html>		</html>
−
−
−

---

Revision as of 05:40, 9 October 2022

tetR-GGGSG-LBD

This composite part consists of an N-terminal tetR(BBa_K4414009) domain and a C-terminal NR3C1 LBD(BBa_K4414000) domain fused with a GGGSG linker. It is designed to sense glucocorticoids and activates the transcription of the reporter gene.

Usage and Biology

As a glucocorticoid sensor, this part is designed to enter the nucleus upon glucocorticoid stimulation and bind to the TCE promoter to activate downstream transcription. This part consists of a tetR DNA binding domain, which binds to the TCE promoter (BBa_K4016011) consisting of seven direct 19-bp tet operator sequence (tetO) repeats. The NR3C1 LBD domain on the C terminal is the ligand binding domain of the glucocorticoid receptor(GR). This LBD domain can translocate the fusion protein into the nucleus upon glucocorticoid stimulation. It also has a transactivating domain 2 (τ2) and an activation function domain 2 (AF2) which activates downstream gene expression.[1]

Figure1. Schematic figure of BBa_K4414024 and BBa_K4414041

Sequence and Features

Method

HEK-293T cells were co-transfected with plasmids encoding both BBa_K4414024 and TCE-SEAP(BBa_K4414041). Cells were treated with 10, 50, or 100 nM Glucocorticoids 6 h post-transfection. Cells without glucocorticoid treatment were used as control. Culture medium was collected at 24 h or 48 h post glucocorticoids treatment. SEAP activity was measured according to a published protocol. [2]

Result

Results showed significantly increased SEAP expression in glucocorticoid-treated cells compared to the non-treated control (2-5 folds). A dose dependence was observed within 0-50 nM of glucocorticoid (Figure 2).

Figure2. Glucocorticoid-stimulated transcriptional activation of SEAP mediated by BBa_K4414024.

Reference

[1]Weikum ER, Knuesel MT, Ortlund EA, Yamamoto KR. Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat Rev Mol Cell Biol. 2017 Mar;18(3):159-174. doi: 10.1038/nrm.2016.152. Epub 2017 Jan 5. PMID: 28053348; PMCID: PMC6257982. [2]Shao J, Qiu X, Xie M. Engineering Mammalian Cells to Control Glucose Homeostasis. Methods Mol Biol. 2021;2312:35-57. doi: 10.1007/978-1-0716-1441-9_3. PMID: 34228283.